Applications published 14 February 2007
Immunostimulant compsn comprising at least one toll-like receptor 7 or toll-like receptor 8 agonist and toll-like receptor 4 agonist
Sanofi Pasteur 1750707*
Combinations of substituted 1-phenyl-1,5-dihydro-pyrido-[3,2-B] indol-2-ones and other HIV inhibitors
Tibotec Pharmaceuticals 1750708*
Method for the treatment of back pain
Pain Therapeutics 1750709*
Neuroprotective properties of dextrorotatory morphinans
Kim, Hyoung-Chun; Green Cross 1750710*
Treatment of neurodegenerative and inflammatory conditions with morphinan
The Government of the United States of America, represented by the Secretary, Department of Health and Human Services 1750711*
Medicaments containing N-sulphamoyl-N"-arylpiperazines for the prophylaxis or treatment of obesity and related conditions
Solvay Pharmaceuticals 1750712*
Use of IMATINIB to treat liver disorders and viral infections
Bioniche Life Sciences 1750713*
Phosphoinositide 3-kinase delta selective inhibitors for inhibiting angiogenesis
Vanderbilt University; Icos 1750714*
Methods for treating mast cell disorders
Icos 1750715*
Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin
Sloan-Kettering Institute for Cancer Research 1750716*
Controlled release pharmaceutical compsns with improved bioavailability
Rubicon Research Private 1750717*
Acyclovir formulations
Emisphere Technologies 1750718*
Treatment of diseases associated with altered level of amyloid beta peptides
Boehringer Ingelheim International 1750719*
Hepoxilins and modulators of ichythin for treating skin disorders
INSERM (Institut National de la Sante et de la Recherche Medicale); Consortium Nat. Recherche & Genomique 1750720*
Topical cromolyn formulations
Emisphere Technologies 1750721*
Novel lysophosphatidic acid receptor selective antagonists
University of Virginia Patent Foundation 1750722*
Carotenoid analogues or derivatives for the inhibition and amelioration of inflammation
Hawaii Biotech 1750723*
Method for improving cognitive function by co-administration of a GABAB receptor antagonist and an acetylcholinesterase inhibitor
The Johns-Hopkins University 1750724*
Compsns comprising mannose phosphate for vaginal treatment
Kimberly-Clark Worldwide 1750725*
Spermicidal and virucidal properties of various forms of sophorolipids
Gross, Richard A; Shah, Vishal 1750726*
Kinase modulators and methods of use
Exelixis 1750727*
Prevention of arterial restenosis with active vitamin D compounds
Novacea 1750728*
Solid dosage form of wetted heparin
Emisphere Technologies 1750729*
Treatment of hypercholesterolemia, hypertriglyceridemia and cardiovascular-related conditions using phospholipase-A2 inhibitors
Ilypsa 1750730*
Supplement containing carotenoid, nicotinamide, zinc, water soluble extract of uncaria species and method using the same
Pero, Ronlad, Giampapa, Vincent 1750731*
Cancer cell growth inhibition by black bean (phaseolus vulgaris L) extracts
Istituto Tecnologico y de Estudios Superiores de Monterrey 1750732*
Method of administering porcine B-domainless fVIII
Emory University; Octagen 1750733*
Method of preparation and use of fibrinolytic enzymes in the treatment of disease
Health Enhancement Products 1750734*
Use of an Aloysia/Vebrena/Lippia triphylla/citridora for treating chronic and/or inflammatory diseases
Anoxymer 1750735*
Uses for the extract of plant of the family asclerpidacaea
Cognis France 1750736*
Improved method for identifying peptides in a biological sample
Perkin Elmer 1750737*
Microbial biosurfactants as agents for controlling pests
Awada, Salam; Spendlove, Rex; Awada, Mohammed 1750738*
Oxygenated dibenzo-alpha-pyrone chromoproteins
Natreon 1750739*
Treatment of membrane-associated diseases and disorders using lantibiotic containing compsns
Molichem Medicines 1750740*
Methods of treating diseases with random copolymers
Peptimmune 1750741*
Oral formulations comprising bone morphogenetic proteins for treating metabolic bone diseases
GlaxoSmithKline 1750743*
Medicament for the treatment of fungal infections, particularly aspergillosis
Sigma-Tau Industrie Farmaceutiche Riunite 1750744*
Methods of inhibiting proinflammatory cytokine expression using ghrelin
The United States of America, represented by the secretary, Department of Health and Human Services 1750745*
Methods of using IL-1 antagonists to treat autoinflammatory diseases
Regeneron Pharmaceuticals 1750746*
Soluble LFA-3 polypeptide for treating viral disorders
Astellas 1750747*